News & Insights
Sort By
Insights 326 Results
Insights
|June 29, 2026
Client Insight: Quarterly Employment Law Update – Spring 2026
The second quarter of 2026 marks a key inflection point for employment compliance, with new requirements already taking effect and additional obligations scheduled through 2027. This update highlights the developments most relevant to innovation-economy employers, including emerging AI regulations, a sweeping retroactive noncompete ban in Washington, expanding pay transparency mandates, new hiring and monitoring restrictions, evolving leave laws, and the practical steps employers can take now to prepare policies, templates, and HR processes.
Insights
|May 21, 2026
Gunderson Dettmer contributed the Singapore chapters of Legal 500’s Venture Capital Country Comparative Guides 2026 and Chambers and Partners Venture Capital Global Practice Guide 2026.
Insights
|May 4, 2026
Gunderson Dettmer Releases 2025 Venture Capital Report
Gunderson Dettmer has released its 2025 year‑in‑review venture capital report, analyzing data collected from the thousands of venture financing transactions in which the firm represented clients during 2025 and into the first quarter of 2026. The report examines market trends in deal count, valuation and transaction size across stages, with a spotlight on the role of artificial intelligence (AI) in reshaping the venture ecosystem. Included throughout are insights from Gunderson Dettmer partners, who have negotiated more venture financings than any other law firm every year for the past decade, according to PitchBook.
Events 116 Results
Events
|June 9, 2026
In this third installment of the series, Tim Ehrlich, chair of Gunderson Dettmer’s Life Sciences Group, interviewed Jefferies vice chairman of Global Healthcare Investment Banking Phil Ross
Events
|March 31, 2026
This session gives CFOs and GCs of late-stage private companies a practical, end-to-end IPO roadmap—from drafting the S-1 and structuring the offering to investor meetings, pricing, lockups, and the 2026 market outlook
Events
|March 17, 2026
Post-IPO: Engaging Shareholders with Confidence and Credibility
This webinar equips GCs and CFOs of public companies with strategies to navigate shareholder communications, from annual meetings to investor engagement, with insights from Gunderson Dettmer’s Alexa Belonick and Brett Pletcher
Client News 1,628 Results
Client News
|August 25, 2026
Mexico-Based Primero Raises $12 Million Seed Financing
Mexican startup Primero announces its $12 million seed financing co-led by Kaszek and General Catalyst.
Client News
|August 21, 2026
Gunderson Dettmer Advises Andersen Group on Underwritten Secondary Offering
Andersen Group Inc. (NYSE: ANDG), a leading independent provider of tax, valuation and financial advisory services, announces an underwritten offering of 4,927,125 shares by certain selling stockholders, at a public offering price of $44 per share.
Client News
|August 19, 2026
Amplitude Therapeutics Enters Strategic Collaboration With Lilly
Amplitude Therapeutics, a biotechnology company developing trans-amplifying RNA (taRNA) medicines and vaccines, announces its strategic research collaboration and licensing agreement with Eli Lilly and Company ("Lilly").
Firm News 283 Results
Firm News
|August 27, 2026
As part of its annual list of Massachusetts legal industry leaders, Massachusetts Lawyers Weekly (MLW) has once again recognized Boston partner and Life Sciences practice group chair Tim Ehrlich as a Go To Lawyer in the Health Care and Life Sciences practice area.
Firm News
|August 18, 2026
PitchBook’s Q2 2026 Global League Tables once again recognize Gunderson Dettmer as the most active venture capital law firm worldwide.
Firm News
|August 3, 2026
India Business Law Journal Recognizes Gunderson Dettmer for Excellence in India-Related Work
Gunderson Dettmer has been recognized as a Significant Player in the 2026 edition of India Business Law Journal’s report on the world’s leading international law firms advising on India-related matters.
Blog Posts 65 Results
Public Ventures
|August 21, 2026
SEC to Decrease Filing Fee Rates 37% Effective October 1, 2026 (New Rate $87.00 per $1MM)
The SEC announced today that, effective October 1, 2026—the first day of the federal government’s fiscal year 2027—the fees that public companies and other issuers pay to register their securities with the Commission will decrease to $87.00 per million dollars, from the current $138.10 per million dollars. The reduction is approximately 37%.
Public Ventures
|August 17, 2026
SEC Fully Withdraws from Rule 14a-8 Shareholder Proposal No-Action Process
“[M]y greatest takeaway is that the Commission staff’s interposition between companies and shareholder proponents is unnecessary to effectively and efficiently resolve whether shareholder proposals should be included in proxy statements.”
Public Ventures
|June 1, 2026
‘Dramatic Overreach’ of Authority: SEC Proposes to Rescind Climate Disclosure Rules
“We must re-examine the costs, burdens, and benefits of disclosure mandates to make becoming and remaining a public company more attractive again. SEC disclosure obligations should comply with the Commission’s statutory authority, be guided by materiality as the North Star, avoid the practical effect of dictating corporate behavior, and be imposed only when the expected benefits justify the likely costs and burdens.”